Curis lead gainer as drug stocks climb
March 21, 2011 at 09:53 AM EDT
Shares of Curis are soaring early Monday on a positive study for its skin cancer treatment GDC-0449.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|